[ad_1]
A woman in King County, Washington, United States, died of rare blood clotting syndrome after receiving the “Johnson & Johnson” vaccine against “Covid-19”, according to a statement from the website of public health in Seattle and King County, Americas.
The woman, in her thirties, was vaccinated on August 26 and died on September 7 of a thrombosis with thrombocytopenia syndrome (TTS).
Seattle and King County Public Health said the diagnosis was confirmed by the U.S. Centers for Disease Control and Prevention’s Clinical Immunization Safety Assessment Project. The CDC reported three more confirmed deaths from TTS nationwide, the statement said.
“The safety and well-being of every person who receives a Johnson & Johnson product remains our top priority,” a Johnson & Johnson spokesperson told CNN. “We strongly support raising awareness of the symptoms of rare diseases described in the FDA’s vaccine fact sheet, to ensure that they can be quickly identified and treated effectively,” the spokesperson added. The local health agency has not identified the deceased woman.
But earlier this month, the Oregonian Journal’s website published an obituary for Jessica Berg-Wilson, a 37-year-old Seattle resident, who said she died on September 7 of a bleeding disorder caused by a rare vaccine. The King County Medical Examiner’s Office confirmed to CNN that Wilson died on September 7.
In a statement, the Centers for Disease Control and Prevention said they were aware of the case, with the report citing a “reasonable causal relationship between Johnson & Johnson’s coronavirus vaccine and TTS.” The agency said it would release updated information on TTS cases later this year.
Earlier this year, the Centers for Disease Control and Prevention and the United States Food and Drug Administration recommended stopping use of the Johnson & Johnson vaccine against the Corona virus, after some reports of blood clots appearing in people. having received this vaccine, the majority of which are women, under 50 years of age. Use of the vaccine resumed soon after, with a new warning about the risk of blood clots and clear instructions to healthcare providers on the specific treatment needed.
Health officials noted that the Johnson & Johnson vaccine was safe and effective, and added that the benefits of a single dose far outweigh its risks. In fact, acute blood clots are among the many risks of “Covid-19”, as the virus has caused more than 700,000 deaths in the United States.
More than 186 million people in the United States have been fully vaccinated, while about 15 million have received the Johnson & Johnson vaccine, with few serious side effects.
“TTS is rare,” the Centers for Disease Control and Prevention said. “It occurs at a rate of 7 per million women vaccinated between the ages of 18 and 49. For women 50 and older, and men of all ages, this disease is much rarer.” The Centers for Disease Control and Prevention said people who received the Johnson & Johnson vaccine should watch for symptoms of thrombosis and thrombocytopenia for several weeks after vaccination.
It is important to seek immediate medical attention if any of the following symptoms occur:
Severe or persistent headache or blurred vision
Shortness of breath
chest pain
swelling of the legs
Constant pain in the abdomen
There is no increased risk of developing TTS after receiving the Pfizer-BioNtech and Moderna vaccines, the Centers for Disease Control and Prevention noted.
Source link
